📣 Open Art-Science Call 📣 This combined open call invites applications for FOUR fully funded residencies across the two European Union Horizon projects deCYPher and Bioindustry 4.0. Three artists will be selected to participate in the deCYPher project and one in the Bioindustry 4.0 project. Core to the deCYPher and Bioindustry 4.0 projects is fostering the potential of artistic research and critical thinking towards influencing the practices, processes and developments of science and technology. With this unique opportunity, we seek to foster genuine exchange between the project’s researchers (partners working in research institutes and businesses) and artists, who have the opportunity to learn from and with our partners but also bring their own expertise from working in the field of art and science. deCYPher and Bioindustry 4.0 artists in residence Each artist is offered a 28-day-long fully funded research residency to be undertaken during 2025 and further support for the production of work towards a group exhibition in 2026. The deCYPher residencies will take place in the facilities of the CSB - Centre for Synthetic Biology at Ghent University (Belgium), the department of Bioscience at Wageningen Plant Research (Netherlands), and ML6 | Your partner in AI (Belgium). The Bioindustry 4.0 artist in residence will take place at the Wageningen University & Research (Netherlands) with Prof. Vitor A.P. Martins dos Santos and his Biomanufacturing & Digital Twins research group. 🗓 Deadline for applications is 23 October 2024 by 23:59 (EEST). For full details please check https://lnkd.in/dEmh7SX4.
Bioindustry 4.0
Biotechnology Research
Research Infrastructure services to promote deep digitalization of Industrial Biotechnology and smart biomanufacturing
About us
Industrial Biotechnology (IB) is a Key Enabling Technology for the circular bio-economy, industrial renewal and European manufacturing autonomy. Its development forms a vital part of EU’s strategy to become climate neutral in 2050. For IB to become a major manufacturing technology, it must widen its use of advanced digital technologies. These will improve R&D efficiency, reducing time-to-market and costs. Moreover, for manufacturing, advanced digital technologies will drive distributed, autonomous and highly adaptable production systems. To support digitalization of IB, the Horizon Europe project BIOINDUSTRY 4.0 will create new services delivered by European research infrastructures (RI). These services will address several challenges, focusing on the acceleration of bio-process development pipelines. Drawing on the complementary skills of its consortium, BIOINDUSTRY 4.0 will develop data-driven approaches, exploiting AI to empower novel decision support systems and digital twins, the latter being to better design bio-processes and enable their real-time online control. To complete these services, BIOINDUSTRY 4.0 will also develop data and metadata standards to generate high quality, interoperable multi-scale bio-process data, the technical basis for trusted data networks and process analytical devices to provide real-time online monitoring of bio-processes. Once deployed, these RI services will provide Users with access to cutting-edge technologies that can be used singly or in an integrated way, covering whole R&D pipelines. Integrated services will be delivered by a distributed RI, conferring Europe with a unique R&D test-bed for bio-process development and a competitive advantage with respect to global competition. BIOINDUSTRY 4.0 brings together 6 EU RIs, 1 global company, 2 innovative EU SMEs and several research teams around an ambitious 4-year workplan that will be implemented in consultation with IB stakeholders, using a co-design strategy to specify goals.
- Website
-
https://bioindustry4.hub.inrae.fr/
External link for Bioindustry 4.0
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Founded
- 2023
- Specialties
- biotechnology, infrastructure, digital twin, bioprocess monitoring, bioprocess design, industrial exploitation of microbial biodiversity, data-driven methods and services, Stakeholder engagement, microbial diversity, and industrial biotechnology
Updates
-
Current funding opportunity at the intersection of AI and synthetic biology in the US that also seems to be open for Non-U.S. Organizations. ("Non-U.S. organizations and/or individuals may participate to the extent that such participants comply with any necessary nondisclosure agreements, security regulations, export control laws, and other governing statutes applicable under the circumstances.")
Interested in prediction & health? Submit your ideas to #AIBTO! Transform health w/ tools for early risk assessment, personalized predictions, & safe interventions. Validate #AI #Bio tools, anticipate future impacts & ensure effective democratization. https://lnkd.in/eWEnu4P7
-
-
Bioindustry 4.0 reposted this
We have an open call for for 4 fully funded residencies across the two European Union Horizon projects deCYPher and Bioindustry 4.0. Three artists will be selected to participate in the deCYPher project and one in the Bioindustry 4.0 project. With this unique opportunity, we seek to foster genuine exchange between the project’s researchers (partners working in research institutes and businesses) and artists, who have the opportunity to learn from and with our partners but also bring their own expertise from working in the field of art and science. Deadline for applications is 23rd October 2024. 📌 This is an opportunity for professional artists with experience working within the field of art and science. 📌 We are looking for artists who are curious and constructive in their critical thinking to collaborate on stimulating deeper reflection about convergence of AI/ML and SynBio. 📌 Those selected for the residency should also be available to participate and present within a series of 2 workshop labs organised as part of the project. #opencall #residency #sciart #art #science #synbio #AI #ML #ArtificialIntelligence #MachineLearning #SyntheticBiology Check the details on our website 🔽 https://lnkd.in/d3wicCRC
Open call for HORIZON artists in residence
bioartsociety.fi
-
The #EUResearchArea conference is ongoing. Early morning debate is on financing #research and #innovation. I am unsure whether the 3% GDP target for #EU is meaningful or not. However, I am convinced that our approach to R&I must change. Our approach to research must better valorize risk-taking. Many research programmes encourage timid research activities combined with over strict, ill-adapted financial monitoring. This discourages creativity and makes #EU #science careers less attractive. In France we are priviliged to currently benefit from funding to experiment with high risk-high reward research. The #explorae (https://explorae.inrae.fr) programme operated by INRAE is currently providing researchers from all career stages opportunities to explore ideas in a more flexible research-friendly framework. At a time when European governments are preparing new budgets, let's hope that the value of innovative high risk-high reward programmes are recognized and pursued.
EXPLOR'AE INRAE
explorae.inrae.fr
-
📅 Sep 25, 4pm Looks like a very exciting webinar dealing with modelling techniques and the bioeconomy - and EV Biotech will also release its new strain engineering assistant Optistrain!
I have recently been asked, "How do you use your voice?" 🗣 And in all fairness, as an #introvert and #neurodivergent the answer is "scarcely and quietly". I use my voice mostly in more private settings, internally with my team, or in 1:1 conversations, where I feel safe and heard. But on rare occasions, you can hear me loud and clear in public. That is when I feel strongly about a topic that is being discussed, and I believe that my voice can meaningfully contribute to taking action, teaching, or empowering others. I want to drive the change, not just fill the air with noise. And now, there comes a rare moment, when I feel again bold enough to speak up. In the upcoming webinar for the bioeconomy organised by EV Biotech in collaboration with, Synonym, Arxada, and Bio Base Europe Pilot Plant, together with other panellists we will focus on: - how #modelling can speed up the #commercialization of #bioproducts, - what are the different types of purpose-driven models that assist in scaling up #industrial #bioprocesses, - and also, on current models' shortcomings. Why do I care? I strongly believe that in order to make the #circular #economy a reality now, not in 20 years, we need to use the most up-to-date tools, including digital ones, to de-risk, and speed up the introduction of #bioprocesses on a global scale. 📅 Date: September 25, 2024 🕒 Time: 4pm to 5:30pm CET 📍 Sign up for the webinar here: https://lnkd.in/eCqmmf6j The webinar is part of the 12th edition of the #EuropeanBiotechWeek, a week-long (from 24 September to 1 October 2024) series of events aiming at making #biotech accessible to everyone and showing how it surrounds and supports us in everyday life (more at www.biotechweek.org). EuropaBio - the European Association for Bioindustries
-
https://lnkd.in/duH6bf6k. Check out this video clip from https://lnkd.in/dM3zUeVj. It is a nice reminder (or primer for those that don't know) that #biotechnology is both a familiar, versatile and powerful. Its familiar because Humans have been using it for thousands of years, versatile because it can be used for so many purposes (food, fuels, pharma products etc) and powerful because when combined with the latest digital technologies, it becomes a gamechanging #manufacturing technology that can help #Europe #researchimapactEU to achieve its sustainability targets . Thanks to contributions from its partners, especially #research #infrastructures IBISBA, MIRRI - Microbial Resource Research Infrastructure , Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures, BBMRI-ERIC and ELIXIR Bioindustry 4.0 is striving to deliver digital enhanced biotechnology.
Biotech potential set to soar with the help of digital technology
https://www.youtube.com/
-
We’re less than 10 days away from our highly anticipated Bioindustry 4.0 Summer Webinar! Are you ready? 🌱🔬 Join us on August 29 & 30 for a two-day online event packed with cutting-edge presentations and thought-provoking discussions! Whether you’re passionate about digitalisation, trusted research environments, or domain ontologies, we’ve got something for you. Plus, it's all happening LIVE from the comfort of your office, home or your favourite beach! Don’t miss out! 📅 When: August 29 & 30, 2024 💻 Where: Online via Zoom 📝 How: Free registration -> https://lc.cx/YiKG1w 🔗 Explore the full agenda and meet our lineup of speakers here: https://lnkd.in/dZGTUk22 🎯 Ready to be inspired? Register today and secure your spot! Let’s countdown to the Bioindustry 4.0 Summer Webinar! INRAE, University of Dundee, University of Nottingham, National Technical University of Athens, DTU - Technical University of Denmark, Ghent University #Bioindustry4 #Webinar #DigitalTwins #AI #Biotech #HorizonEU #Innovation #Bioprocess #IndustrialBiotechnology #HorizonEurope
-
Magalie Weber's & Liliana Ibanescu's presentation is not to be missed! Register now to receive the videoconference details! Join us on August 30th to the session discussing how domain ontologies such as PO2/TransformON and FermentON can facilitate the interoperability and reuse of data in various sectors, including (bio)processes, food characterisation, bioproducts, and biowaste. The work focuses on building and managing these ontologies to enhance data sharing and research efficiency in the engineering of food and bioproducts from agri-food systems. 📋 Find out more about the full agenda and speaker bios, of the 2-days Bioindustry 4.0 Summer Webinar, on our website by clicking here: https://lnkd.in/dZGTUk22 📝 To register for free to the webinar -> https://lc.cx/YiKG1w INRAE #Bioindustry4 #Webinar #DigitalTwins #AI #Biotech #HorizonEU #Innovation #Bioprocess #IndustrialBiotechnology #HorizonEurope
-
-
US DARPA invests in biomanufacturing and digital twins as part of its new AI x Biotech program.
We’re looking for new ideas/input at the intersection of biotechnology and AI/ML. #Bio-innovators, blue sky thinkers, and #AI/ML experts, join us in San Francisco (9/13) or Boston (9/20) to discuss key topics of interest and learn about an exciting funding opportunity. Register today: https://lnkd.in/eVhaxN7y
-
🚀 The future of biotech looks promising with the integration of digital technology! 🚀 As we already posted yesterday: we're thrilled to share an insightful interview featuring Michael O'Donohue and our project Bioindustry 4.0 by Anthony King from Horizon Magazine. The piece explores how digital technology is unlocking new potentials in biotechnology, from creating eco-friendly industrial processes to producing high-quality proteins sustainably. 🌱🔬 By integrating advanced digital technologies, Bioindustry 4.0 and all the research infrastructures involved in the project are working together to advance Europe's position in the biotech sector, fostering sustainable industrial processes and driving biotech innovation towards a greener, more efficient future. That's also why so many research infrastructures are involved in the project -the article mentions IBISBA by name, but we're also proud to count BBMRI-ERIC, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Gaia-X Association for Data and Cloud (AISBL), ELIXIR, and MIRRI - Microbial Resource Research Infrastructure as part of our valuable project team. https://lnkd.in/dG8qwGwH
Biotech potential set to soar with the help of digital technology
projects.research-and-innovation.ec.europa.eu